Abstract
We examined the effect of E2 and selective estrogen receptor modulators (SERMs) on the proliferation and estrogen receptor (ER) activities in normal human prostate cells. SERMs such as toremifene, raloxifene and tamoxifen suppressed the proliferation of prostate epithelial and stromal cells whereas anti-androgens did not. In prostate stromal cells, the transactivation activities of ER were enhanced by adding E2 and reduced remarkably by toremifene. The results indicate that the ER-mediated pathway plays a central role in the growth of normal prostate cells.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 4 print issues and online access
$259.00 per year
only $64.75 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Prins GS, Huang L, Birch L, Pu Y . The role of estrogens in normal and abnormal development of the prostate gland. Ann NY Acad Sci 2006; 1089: 1–13.
Prins GS, Korach KS . The role of estrogens and estrogen receptors in normal prostate growth and disease. Steroids 2008; 73: 233–244.
Kuiper GG, Enmark E, Pelt-Huikko M, Nilsson S, Gustafsson J-A . Cloning of a novel receptor expressed in rat prostate and ovary. Proc Natl Acad Sci USA 1996; 93: 5925–5930.
Chang WY, Prins GS . Estrogen receptor β: implication for the prostate gland. Prostate 1999; 40: 115–124.
Lau K-M, LaSpina M, Long J, Ho S-M . Expression of estrogen receptor (ER)-α and ER-β in normal and malignant prosratic epithelial cells: regulation by methylation and involvement in growth regulation. Cancer Res 2000; 60: 3175–3182.
Latil A, Bieche I, Vidaud D, Lidereau R, Berthon P, Cussenot O et al. Evaluation of androgen, estrogen (ERα and ERβ), and progesterone receptor expression in human prostate cancer by real-time quantitative reverse transcription-polymerase chain reaction assays. Cancer Res 2001; 61: 1919–1926.
Royuela M, de Miguel MP, Bethencourt FR, Sanchez-Chapado M, Fraile B, Arenas MI et al. Estrogen receptors α and β in the normal, hyperplastic and carcinomatous human prostate. J Endocrinol 2001; 168: 447–454.
Tsurusaki T, Aoki D, Kanetake H, Inoue S, Muramatsu M, Nishikawa Y et al. Zone-dependent expression of estrogen receptors α and β in human benign prostatic hyperplasia. J Clin Endocrinol Metab 2003; 88: 1333–1340.
Linja MJ, Savinainen KJ, Tammela TL, Isola JJ, Visakorpi T . Expression of ERα and ERβ in prostate cancer. Prostate 2003; 55: 180–186.
Kim IY, Kim B-C, Seong DH, Lee DK, Seo J-M, Hong YJ et al. Raloxifene, a mixed estrogen agonist/antagonist, induces apoptosis in androgen-independent human prostate cancer cell lines. Cancer Res 2002; 62: 5365–5369.
Griffiths K, Denis LJ, Behre HE, Bracke M, Krieg M, Kyprianou N et al. Estrogens and prostatic disease. Prostate 2000; 45: 87–100.
King KJ, Nicholson HD, Assinder SJ . Effect of increasing ratio of estrogen:androgen on proliferation of normal human prostate stromal and epithelial cells, and the malignant cell line LNCaP. Prostate 2006; 66: 105–114.
Zhang Z, Duan L, Du X, Ma H, Park I, Lee C . The proliferative effect of estradiol on human prostate stromal cells is mediated through activation of ERK. Prostate 2008; 68: 508–516.
Krill D, Shuman M, Thompson MT, Becich MJ, Strom SC . A simple method for the isolation and culture of epithelial and stromal cells from benign and neoplastic prostates. Urology 1997; 49: 981–988.
Peehl DM . Primary cell cultures as models of prostate cancer development. Endocr Relat Cancer 2005; 12: 19–47.
Peehl DM, Sellers RG . Cultured stromal cells: an in vitro model of prostatic mesenchymal biology. Prostate 2000; 45: 115–123.
Planz B, Kirley SD, Wang Q, Tabatabaei S, Aretz HT, McDougal WS . Characterization of a stromal cell model of the human benign and malignant prostate from explant culture. J Urol 1999; 161: 1329–1336.
Janßen M, Albrecht M, Möschler O, Renneberg H, Fritz B, Aumüller G et al. Cell lineage characteristics of human prostatic stromal cells cultured in vitro. Prostate 2000; 43: 20–30.
Tran CP, Lin C, Yamashiro J, Reiter RE . Prostate stem cell antigen is a marker of late intermediate prostate epithelial cells. Mol Cancer Res 2002; 1: 113–121.
Garraway LA, Lin D, Signoretti S, Waltregny D, Dilks J, Bhattacharya N et al. Intermediate basal cells of the prostate: in vitro and in vivo characterization. Prostate 2003; 55: 206–218.
Weihua Z, Mäkelä S, Andersson LC, Salmi S, Saji S, Webster JI et al. A role for estrogen receptor βin the regulation of growth of the ventral prostate. Proc Natl Acad Sci USA 2001; 98: 6330–6335.
Weihua Z, Lathe R, Warner M, Gustafsson J . An endocrine pathway in the prostate, ERβ, AR, 5α-androstane-3β, 17β-diol, and CYP7B1, regulates prostate growth. Proc Natl Acad Sci USA 2002; 99: 13589–13594.
Horvath LG, Henshall SM, Lee C-S, Head DR, Quinn DI, Makela S et al. Frequent loss of estrogen receptor-β expression in prostate cancer. Cancer Res 2001; 61: 5331–5335.
Leav I, Lau K-M, Adams JY, McNeal JE, Taplin M-E, Wang J et al. Comparative studies of the estrogen receptors β and α and the androgen receptor in normal human prostate glands, dysplasia, and in primary and metastatic carcinoma. Am J Pathol 2001; 159: 79–92.
Fixemer T, Remberger K, Bonkhoff H . Differential expression of the estrogen receptor β (ERβ) in human prostate tissue, premalignant changes, and in primary, metastatic and recurrent prostatic adenocarcinoma. Prostate 2003; 54: 79–87.
Hurtado A, Pinos T, Barbosa-Desongles A, Lopez-Aviles S, Barquinero J, Petriz J et al. Estrogen receptor beta displays cell cycle-dependent expression and regulates the G1 phase through a non-genomic mechanism in prostate carcinoma cells. Cell Oncol 2008; 30: 349–365.
Walton TJ, Li G, Seth R, McArdle ES, Bishop MC, Rees RC . DNA demethylation and histone deacetylation inhibition co-operate to re-express estrogen receptor beta and induce apoptosis in prostate cancer cell-lines. Prostate 2008; 68: 210–222.
Torlakovic E, Lilleby W, Torlakovic G, Fossa SD, Chibber R . Prostate carcinoma expression of estrogen receptor-β as detected by PPG5/10 antibody has positive association with primary Gleason grade and Gleason score. Hum Pathol 2002; 33: 646–651.
Walton TJ, Li G, McCulloch TA, Seth R, Powe DG, Bishop MC et al. Quantitative RT-PCR analysis of estrogen receptor gene expression in Laser microdissected prostate cancer tissue. Prostate 2009; 69: 810–819. Published online 2 Feb.
Singh PB, Matanhelia SS, Martin FL . A potential paradox in prostate adenocarcinoma progression: oestrogen as the initiating driver. Eur J Cancer 2008; 44: 928–936.
Ricke WA, McPherson SJ, Bianco JJ, Cunha GR, Wang Y, Risbridger GP . Prostatic hormonal carcinogenesis is mediated by in situ estrogen production and estrogen receptor alpha signaling. FASEB J 2008; 22: 1512–1520.
Collins AT, Zhiming B, Gilmore K, Neal DE . Androgen and oestrogen responsiveness of stromal cells derived from the human hyperplastic prostate: oestrogen regulation of the androgen receptor. J Endocrinol 1994; 143: 269–277.
Zhang J, Hess MW, Thurnher M, Hobisch A, Radmayr C, Cronauer MV . Human prostatic smooth muscle cells in culture: estradiol enhances expression of smooth muscle cell-specific markers. Prostate 1997; 30: 117–129.
Planz B, Wang Q, Kirley SD, Lin C-W, McDougal WS . Androgen responsiveness of stromal cells of the human prostate: regulation of cell proliferation and keratinocyte growth factor by androgen. J Urol 1998; 160: 1850–1855.
Minamiguchi K, Kawada M, Someno T, Ishizuka M . Androgen-independent prostate cancer DU145 cells suppress androgen-dependent growth of prostate stromal cells through production of inhibitory factors for androgen responsiveness. Biochem Biophys Res Commun 2003; 306: 629–636.
Nakano K, Fukabori Y, Itoh N, Lu W, Kan M, McKeehan WL et al. Androgen-stimulated human prostate epithelial growth mediated by stromal-derived fibroblast growth factor-10. Endocr J 1999; 46: 405–413.
Chen M, Ni J, Zhang Y, Muyan M, Yeh S . ERAP75 functions as a coactivator to enhance estrogen receptor α transactivation in prostate stromal cells. Prostate 2008; 68: 1273–1282.
Wang J, Shiozawa Y, Wang J, Wang Y, Jung Y, Pienta KJ et al. The role of CXCR7/RDC1 as a chemokine receptor for CXCL12/SDF-1 in prostate cancer. J Biol Chem 2008; 283: 4283–4294.
Lewandowski S, Kalita K, Kaczmarek L . Estrogen receptor β: potential functional significance of a variety of RNA isoforms. FEBS Lett 2002; 524: 1–5.
Leung Y-K, Gao Y, Lau K-M, Zhang X, Ho S-M . ICI 182,780-regulated gene expression in DU145 prostate cancer cells is mediated by estrogen receptor-β/NFκB crosstalk. Neoplasia 2006; 8: 242–249.
Matsumura K, Tanaka T, Kawashima H, Nakatani T . Involvement of the estrogen receptor β in genistein-induced expression of p21 waf1/cip1 in PC-3 prostate cancer cells. Anticancer Res 2008; 28: 709–714.
Casella R, Bubendorf L, Schaefer DJ, Bachmann A, Gasser TC, Sulser T . Does the prostate really need androgens to grow? Transurethral resection of the prostate in a male-to-female transsexual 25 years after sex-changing operation. Urol Int 2005; 75: 288–290.
Price D, Stein B, Sieber P, Tutrone R, Bailen J, Goluboff E et al. Toremifene for the prevention of prostate cancer in men with high grade prostatic intraepithelial neoplasia: results of a double-blind, placebo controlled phase IIB clinical trial. J Urol 2006; 176: 965–970.
Acknowledgements
We thank Dr Shigeaki Kato, Tokyo University, for providing us with pGL3-ERE-X3tK luc (pERE-luc). We also thank Nippon Kayaku Corp. (Tokyo, Japan) for flutamide and toremifene. This work was supported in part by grants from Osaka City University Medical Research Foundation.
Author information
Authors and Affiliations
Corresponding author
Additional information
Conflict of interest
The authors declare no conflict of interest.
Rights and permissions
About this article
Cite this article
Nomura, H., Kawashima, H., Masaki, S. et al. Effect of selective estrogen receptor modulators on cell proliferation and estrogen receptor activities in normal human prostate stromal and epithelial cells. Prostate Cancer Prostatic Dis 12, 375–381 (2009). https://doi.org/10.1038/pcan.2009.20
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/pcan.2009.20
Keywords
This article is cited by
-
Which play a more important role in the development of large-sized prostates (≥80 ml), androgen receptors or oestrogen receptors? A comparative study
International Urology and Nephrology (2016)
-
Selective estrogen receptor modulators for BPH: new factors on the ground
Prostate Cancer and Prostatic Diseases (2013)
-
Selective estrogen receptor modulators regulate stromal proliferation in human benign prostatic hyperplasia by multiple beneficial mechanisms—action of two new agents
Investigational New Drugs (2012)
-
Estrogen and androgen signaling in the pathogenesis of BPH
Nature Reviews Urology (2011)
-
Antagonism of estrogen-mediated cell proliferation by raloxifene in prevention of ageing-related prostatic hyperplasia
Asian Journal of Andrology (2010)